UNITAID is in talks with makers of AIDS drugs about a patent pool

07/21/2010 | Reuters

UNITAID is in advanced negotiations with Merck & Co., Gilead Sciences and Johnson & Johnson subsidiary Tibotec about licensing their AIDS treatments to generic-drug makers in developing nations, through a patent pool. The health-funding agency singled out 19 drugs from nine companies for possible inclusion in the pool.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ